famotidine 40mg tablets
de pharmaceuticals - famotidine - oral tablet - 40mg
famotidine teva 20 mg
teva pharmaceutical industries ltd, israel - famotidine - tablets - famotidine 20 mg - famotidine - famotidine - treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.
famotidine teva 40 mg
teva pharmaceutical industries ltd, israel - famotidine - tablets - famotidine 40 mg - famotidine - famotidine - treatment of duodenal ulcer, benign gastric ulcer, pathological hypersecretory conditions such as zollinger-ellison syndrome, gastroesophageal reflux disease. prevention of relapses of duodenal ulceration.
famotidine teva 40 mg
teva israel ltd - famotidine - tablets - famotidine 40 mg - famotidine - treatment of duodenal ulcer, benign gastric ulcer, pathological hypersecretory conditions such as zollinger-ellison syndrome, gastroesophageal reflux disease. prevention of relapses of duodenal ulceration.
famotidine teva 40 mg
teva pharmaceutical industries ltd, israel - famotidine - tablets - famotidine 40 mg - famotidine - treatment of duodenal ulcer, benign gastric ulcer, pathological hypersecretory conditions such as zollinger-ellison syndrome, gastroesophageal reflux disease. prevention of relapses of duodenal ulceration.
famotidine clonmel 20 mg film-coated tablets
clonmel healthcare ltd - famotidine - film-coated tablet - 20 milligram(s) - famotidine
famotidine clonmel 40 mg film-coated tablets
clonmel healthcare ltd - famotidine - film-coated tablet - 40 milligram(s) - famotidine
peptris famotidine 40mg film-coated tablet blister pack
strides pharma science pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - symptomatic relief of heartburn, dyspepsia and indigestion due to gastro-oesophageal reflux in adults over 18 years of age. for the treatment of duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration. short-term (no more than 12 weeks) symptomatic relief of gastro-oesophageal reflux not responsive to conservative measures. healing of oesophageal erosion or ulceration associated with gastro-oesophageal reflux disease. prevention of relapses of symptoms and erosions or ulcerations associated with gastro-oesophageal reflux disease.
famotren famotidine 40mg film-coated tablet blister pack
strides pharma science pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - symptomatic relief of heartburn, dyspepsia and indigestion due to gastro-oesophageal reflux in adults over 18 years of age. for the treatment of duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration. short-term (no more than 12 weeks) symptomatic relief of gastro-oesophageal reflux not responsive to conservative measures. healing of oesophageal erosion or ulceration associated with gastro-oesophageal reflux disease. prevention of relapses of symptoms and erosions or ulcerations associated with gastro-oesophageal reflux disease.
famistine famotidine 40mg film-coated tablet blister pack
medis pharma pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - symptomatic relief of heartburn, dyspepsia and indigestion due to gastro-oesophageal reflux in adults over 18 years of age. for the treatment of duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration. short-term (no more than 12 weeks) symptomatic relief of gastro-oesophageal reflux not responsive to conservative measures. healing of oesophageal erosion or ulceration associated with gastro-oesophageal reflux disease. prevention of relapses of symptoms and erosions or ulcerations associated with gastro-oesophageal reflux disease.